The Impact of Preoperative Radiochemotherapy on Survival in Advanced Esophagogastric Junction Signet Ring Cell Adenocarcinoma  Sarah Bekkar, MD, Caroline.

Slides:



Advertisements
Similar presentations
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Advertisements

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,
Trevor Williams, MD, MPH, Brian C
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Lung Cancer Staging: A Case for a New T Definition
Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis  Andrew J. Graham, MD, MS, Fiona M. Shrive,
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Heart Transplantation for the Failing Fontan
Cooperative Group Clinical Trials in General Thoracic Surgery: Report From the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical.
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Burdens Without Blessings: Peer Reviewers Get No Respect
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Trimodal Therapy for Histologically Proven N2/3 Non–Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival  Volker Steger, MD, Thorsten.
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival  Daniel L. Miller, MD, William R. Mayfield, MD,
Pleural Metastasis of Osteosarcoma
Surgical Repair of a Chronic Traumatic Sternal Fracture
Trevor Williams, MD, MPH, Brian C
Performing Coronary Artery Bypass Grafting Off-Pump May Compromise Long-Term Survival in a Veteran Population  Faisal G. Bakaeen, MD, Danny Chu, MD, Rosemary.
Surgical Resection of Rare Esophageal Cancers
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Origins of the Cardiothoracic Surgery Network (CTSNet)
Who Do You Say You Are? The Annals of Thoracic Surgery
Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis  Bryan A. Whitson, MD, PhD, Shawn S.
Use of Amiodarone After Major Lung Resection
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Abel Gómez-Caro, MD, Pedro Arguis, MD  The Annals of Thoracic Surgery 
Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M
Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D
Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database  Mark Onaitis,
Evidence-Based and Personalized Medicine. It’s [AND] not [OR]
Hybrid Management of a Giant Left Main Coronary Artery Aneurysm
Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty
Editorial Board, January 2010
Bradford B. Smith, MD, Matthew A
Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD 
Understanding Mortality as a Quality Indicator After Esophagectomy
Factors predictive of complete resection of operable esophageal cancer: a prospective study  Christophe Mariette, MD, Laetitia Finzi, MD, Sylvain Fabre,
Comparison of Prognosis of Solid and Part-Solid Node-Negative Adenocarcinoma With the Same Invasive Component Size  Kyung Wook Shin, MD, Sukki Cho, MD,
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve  Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD 
Specialty Training and Mortality After Esophageal Cancer Resection
Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer  Pamela Samson, MD, MPHS, Varun.
Impact of Functional Status on Survival After Coronary Artery Bypass Grafting in a Veteran Population  Roberto Cervera, MD, Faisal G. Bakaeen, MD, Lorraine.
Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer?  Williams Tessier, MD, Caroline Gronnier, MD,
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
Robert Lee Replogle, September 30, 1931–May 9, 2016
Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection  Daniel L. Miller, MD, Gerald A. Helms, MD,
The American Board of Thoracic Surgery: Update
Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis  Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.
Sagar U. Nigwekar, MD, Praveen Kandula, MD, MPH 
Yangfeng Tang, MD, Zilin Liao, MD, Lin Han, MD, Zhiyun Xu, MD 
Mark I. Block, MD  The Annals of Thoracic Surgery 
Late Consequences of a Much Earlier Decision
Alexander H. Moskovitz, MD, Nabil P
The Impact of New Technology on Cardiothoracic Surgical Practice
Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support  Peter B. Manning, MD, Michael J. Rutter, MD,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy  Tomas Gudbjartsson,
Lung Cancer Invading the Pericardium: Quantum of Lymph Nodes
Presentation transcript:

The Impact of Preoperative Radiochemotherapy on Survival in Advanced Esophagogastric Junction Signet Ring Cell Adenocarcinoma  Sarah Bekkar, MD, Caroline Gronnier, MD, PhD, Mathieu Messager, MD, William B. Robb, MD, Guillaume Piessen, MD, PhD, Christophe Mariette, MD, PhD  The Annals of Thoracic Surgery  Volume 97, Issue 1, Pages 303-310 (January 2014) DOI: 10.1016/j.athoracsur.2013.09.010 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Flow chart of the study. (EGJ = esophagogastric junction; SRC = signet ring cell adenocarcinoma; UICC = Union Internationale Contre le Cancer.) The Annals of Thoracic Surgery 2014 97, 303-310DOI: (10.1016/j.athoracsur.2013.09.010) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival curve in the overall population (hatch marks indicate censored events). The number of subjects at risk at each interval is shown in the table at the bottom of the graph. The Annals of Thoracic Surgery 2014 97, 303-310DOI: (10.1016/j.athoracsur.2013.09.010) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Survival curves after primary surgery (group S [heavy line]; hatch marks indicate censored events in group S) and radiochemotherapy followed by surgery (group RCT [light line]; hatch marks indicate censored evens in group RCT). The number of subjects at risk at each interval is shown in the table at the bottom of the graph. The Annals of Thoracic Surgery 2014 97, 303-310DOI: (10.1016/j.athoracsur.2013.09.010) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions